You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pustular

Showing 26 - 50 of 716
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis Trial in Worldwide (Risankizumab, Placebo for Risankizumab)

Active, not recruiting
  • Psoriasis
  • Glendale, Arizona
  • +54 more
Mar 2, 2022

Generalized Pustular Psoriasis (GPP), Adalimumab, Japanese Trial (Adalimumab)

Completed
Has Results
  • Generalized Pustular Psoriasis (GPP)
  • +2 more
  • (no location specified)
Jul 16, 2018

Psoriasis Trial in Japan (Secukinumab)

Completed
Has Results
  • Psoriasis
  • Secukinumab
  • Fukuoka city, Fukuoka, Japan
  • +9 more
Mar 14, 2019

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease

Active, not recruiting
  • Metabolic Disease
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Clinical Aspect of Erosive Pustular Dermatosis of the Leg

    Completed
    • Erosive Pustular Dermatosis of the Leg
    • Clinical examination
    • Reims, France
      Damien JOLLY
    Aug 7, 2018

    Pyoderma Gangrenosum Trial in New York (Spesolimab)

    Recruiting
    • Pyoderma Gangrenosum
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 16, 2023

    Necrobiosis Lipoidica Trial in Philadelphia, Pittsburgh (PCS499)

    Completed
    Has Results
    • Necrobiosis Lipoidica
    • Philadelphia, Pennsylvania
    • +1 more
    Sep 1, 2022

    Tunisian National Registry on Psoriasis

    Not yet recruiting
    • Psoriasis
      • Tunis, Tunisia
        Société Tunisienne de Dermatologie et de Vénéréologie
      Feb 17, 2022

      Psoriasis Trial in Worldwide (Apremilast (CC-10004), Placebo)

      Active, not recruiting
      • Psoriasis
      • Apremilast (CC-10004)
      • Placebo
      • Birmingham, Alabama
      • +98 more
      Nov 10, 2022

      Disease State in Adult Participants Being Treated With Humira in

      Recruiting
      • Pyoderma Gangrenosum
        • Nagoya shi, Aichi, Japan
        • +44 more
        Jan 13, 2023

        Mycobacterium Abscessus Infection in Chronic Lung Disease and

        Enrolling by invitation
        • Mycobacterium Abscessus Infection
        • +2 more
        • Appropriate treatment
        • Pathum Wan, Bangkok, Thailand
          King Chulalongkorn Memorial Hospital
        Aug 31, 2022

        NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        Nov 7, 2023

        Plaque Psoriasis Trial in Worldwide (Apremilast, Placebo, Topical or Phototherapy Therapy)

        Completed
        Has Results
        • Plaque Psoriasis
        • Phoenix, Arizona
        • +45 more
        Mar 3, 2022

        Skin Diseases and Pregnancy: Which Heathcare Professionals ?

        Completed
        • Skin Abnormalities
        • Pregnancy
        • questionnaire
        • La Roche sur Yon, France
          CHD Vendée
        Sep 8, 2021

        Plaque Psoriasis Trial (Apremilast, Placebo, Topical treatments or phototherapy)

        Completed
        Has Results
        • Plaque Psoriasis
        • (no location specified)
        Mar 3, 2022

        Acne Trial in Manhattan Beach (TheraClearX)

        Active, not recruiting
        • Acne
        • TheraClearX
        • Manhattan Beach, California
          Ablon Skin Institute & Research Center
        Sep 15, 2023

        Palmoplantar Pustular Psoriasis Trial in Worldwide (Secukinumab 300mg, Secukinumab 150mg, Placebo)

        Completed
        Has Results
        • Palmoplantar Pustular Psoriasis
        • Secukinumab 300mg
        • +2 more
        • Feldkirch, Austria
        • +67 more
        Jan 1, 2019

        Benefit of Natalizumab At-home Infusion vs At-hospital Infusion

        Recruiting
        • Multiple Sclerosis (MS)
        • At-home natalizumab treated MS patient
        • Strasbourg, Bas-Rhin, France
        • +19 more
        Mar 22, 2022

        Squamous Cell Carcinoma of the Head and Neck Trial in Cleveland (Pembrolizumab, IMRT 60-66Gy)

        Completed
        Has Results
        • Squamous Cell Carcinoma of the Head and Neck
        • Cleveland, Ohio
        • +1 more
        Jun 29, 2022

        Giant Cell Arteritis Trial in Worldwide (Guselkumab, Placebo)

        Recruiting
        • Giant Cell Arteritis
        • Kansas City, Kansas
        • +33 more
        Aug 11, 2022

        Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi

        Completed
        • Cutaneous Manifestations
        • +7 more
          • Karachi, Sindh, Pakistan
            Jinnah Postgraduate Medical Centre
          Nov 12, 2021

          Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)

          Active, not recruiting
          Has Results
          • Alveolar Soft Part Sarcoma
          • Soft Tissue Sarcomas
          • Miami, Florida
            University of Miami
          Dec 29, 2022

          Psoriasis, Psoriatic Arthritis Trial in Worldwide (Apremilast, Etanercept, Placebo tablet)

          Completed
          Has Results
          • Psoriasis
          • Psoriatic Arthritis
          • Phoenix, Arizona
          • +81 more
          Mar 3, 2022

          Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

          Completed
          Has Results
          • Myelodysplastic Syndrome
          • SyB L-1101
          • Nagoya, Aichi, Japan
          • +2 more
          Nov 14, 2022

          Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

          Completed
          Has Results
          • Metastatic Colorectal Cancer
          • MSS
          • Heidelberg, Germany
            National Center for Tumor Diseases, University Hospital Heidelbe
          May 17, 2022